OmicsDI
Toggle navigation
Browse
Submit Data
Databases
API
Help
Advanced
Search
11
Results
Show all
Save search
Copy query
Show results for
Unknown
(11)
Publication Date
Release Date
2025
(3)
2024
(3)
2023
(2)
2026
(1)
2022
(1)
2021
(1)
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
Defining the causes of sporadic Parkinson's disease in the global Parkinson's genetics program (GP2).
Not available
S-EPMC10497609
|
biostudies-literature
Cite
TMEM175, SCARB2 and CTSB associations with Parkinson's disease risk across populations.
Not available
S-EPMC12678402
|
biostudies-literature
Cite
GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians.
Not available
S-EPMC12164542
|
biostudies-literature
Cite
Identification of genetic risk loci and causal insights associated with Parkinson's disease in African and African admixed populations: a genome-wide association study.
Not available
S-EPMC10593199
|
biostudies-literature
Cite
The LRRK2 p.L1795F variant causes Parkinson's disease in the European population.
Not available
S-EPMC11937388
|
biostudies-literature
Cite
Multi-ancestry genome-wide association meta-analysis of Parkinson's disease.
Not available
S-EPMC10786718
|
biostudies-literature
Cite
Scaling and networking a modular photonic quantum computer.
Not available
S-EPMC11864973
|
biostudies-literature
Cite
Association of LRRK2 p.A419V with Parkinson's Disease in East Asians and analysis of age at onset.
Not available
S-EPMC12913921
|
biostudies-literature
Cite
Safety of the PCSK9 inhibitor alirocumab: insights from 47 296 patient-years of observation.
Not available
S-EPMC11249957
|
biostudies-literature
Cite
Apolipoprotein B, Residual Cardiovascular Risk After Acute Coronary Syndrome, and Effects of Alirocumab.
Not available
S-EPMC9422774
|
biostudies-literature
Cite
Previous
page
1 / 2
You're on page
1
page
2
Next
page
Sort
by:
Relevance
Page size
10
OmicsDI
is part of the ELIXIR infrastructure
OmicsDI is an Elixir interoperability service.
Learn more ›
Tweets